A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer. - Wikidata - awgldk - TriplyDB

A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer.

A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer.

http://www.wikidata.org/entity/Q37174037

about

CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial.Patients Administered Neoadjuvant Chemotherapy Could be Enrolled into an Enhanced Recovery after Surgery Program for Locally Advanced Gastric Cancer.

P2860

Q37592211-475D8F2F-7F7B-4384-A417-7A59BD838AD0 Q49941215-8761A2E4-3A8A-4F26-B4BB-7CA5DFF8B0DE

P2860

A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer.

http://www.wikidata.org/entity/Q37174037

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A phase II study of a modified ...... cally advanced gastric cancer.

@en

A phase II study of a modified ...... cally advanced gastric cancer.

@nl

type

label

A phase II study of a modified ...... cally advanced gastric cancer.

@en

A phase II study of a modified ...... cally advanced gastric cancer.

@nl

prefLabel

A phase II study of a modified ...... cally advanced gastric cancer.

@en

A phase II study of a modified ...... cally advanced gastric cancer.

@nl

P1433

Q37174037-1DA276EA-9002-4826-AA24-E9A5381C2449

P1476

Q37174037-A5FE0E6F-E374-4052-8A8D-26A3B1EB5965

P2093

Q37174037-25870B75-CD69-471F-9296-3D9F76E8409D

Q37174037-56EEC659-E961-43E0-A4DB-8D74AEA3B9CA

Q37174037-5916F147-A55B-4DA1-A50F-7D23200A4822

Q37174037-5BE2E9C5-B19D-4861-8D1F-1393FBA5C5C1

Q37174037-6071397A-D910-4301-9299-F60D929E3503

Q37174037-721CA06E-C724-4A30-9A08-0C8D7773EE72

Q37174037-7C4ADFAB-A6CE-4C49-90E5-C8A6EA73A772

Q37174037-8C8D2385-A2AD-456E-AAF4-D4563C21288B

Q37174037-D907A9DA-E625-4BBE-8EE8-3E09FB949554

Q37174037-E1C8A9DD-DE94-470A-B895-39C63BDF40C1

P2860

Q37174037-04BD8B1F-944B-42F9-9413-4B24FAE8BB9D

Q37174037-054429D6-1044-400F-B403-8112EC4F2CB9

Q37174037-0DC4229F-54CA-4980-9730-019B22EC783C

Q37174037-11594C46-71E3-445D-8807-F4506EC66560

Q37174037-1B8A49E3-13CC-4E48-8411-ECFA045DC120

Q37174037-315EF2CB-495E-4DB5-9D13-8B83E5078B6E

Q37174037-3251BEFA-738A-4457-BDA3-65676FD2C0CB

Q37174037-3260D9C4-64F9-4853-AB55-F24657CA2FE9

Q37174037-452BF023-FAFD-4E89-8B9E-3A4EC3597192

Q37174037-45624563-AB74-4AED-864F-2051D131646A

P2888

Q37174037-886E2578-F724-4BED-9AC7-7DE7C1BAD2B7

P304

Q37174037-E60F1E1D-4E32-4016-AA78-75AEA1E7ECA3

P31

Q37174037-B862CE82-DC84-4620-A7DE-B715CE1EEFC8

P356

Q37174037-C8FC54FD-E0FC-4AB9-AC8D-35FECDD2B604

P407

Q37174037-73E86A7E-50F4-4626-80F0-5595CCF3C146

P433

Q37174037-325F1F41-6D0C-4984-B619-FE3A40C10B47

P478

Q37174037-4515D569-824F-43AE-966B-70C1F5669C4B

P577

Q37174037-ADAF44C8-6B57-4176-B765-242FD4648B9C

P698

Q37174037-46325225-84AA-46D1-BE10-3879DD273A0F

P921

Q37174037-0DB7947A-448C-4402-961D-ECB22701B9D4

P932

Q37174037-E3B7ABF3-3EDC-4073-86A8-3780AA2C5840

P356

P1433

British Journal of Cancer

P1476

A phase II study of a modified ...... cally advanced gastric cancer.

@en

P2093

Chunmei Bai

http://www.w3.org/2001/XMLSchema#string

Dingrong Zhong

http://www.w3.org/2001/XMLSchema#string

Fen Dong

http://www.w3.org/2001/XMLSchema#string

Guangliang Shan

http://www.w3.org/2001/XMLSchema#string

Hongfeng Liu

http://www.w3.org/2001/XMLSchema#string

Lin Zhao

http://www.w3.org/2001/XMLSchema#string

Wei Liu

http://www.w3.org/2001/XMLSchema#string

Weisheng Gao

http://www.w3.org/2001/XMLSchema#string

Xiang Wang

http://www.w3.org/2001/XMLSchema#string

Xiaoyi Li

http://www.w3.org/2001/XMLSchema#string

P2860

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker.

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients.

Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer.

Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer.

Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer.

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.

Phase II study of oxaliplatin in combination with continuous infusion of 5-fluorouracil/leucovorin as first-line chemotherapy in patients with advanced gastric cancer.

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.

A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.

P2888

P304

1326-1333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2016.126

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27172250

http://www.w3.org/2001/XMLSchema#string

P921

P932

4984457

http://www.w3.org/2001/XMLSchema#string